220 participants
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2024-05-20
- Completion:
- 2029-01-15
Conditions
- Prostatic Neoplasms, Castration-Resistant
Interventions
- DRUG
No Results Yet